跳至主要内容
临床试验/JPRN-UMIN000013916
JPRN-UMIN000013916已完成未知

Effect of monthly minodronate after switching from raloxifene hydrochloride for the treatment of postmenopausal osteoporosis in women with loss of ovarian function due to gynecologic malignancies - Effect of monthly minodronate for the treatment of osteoporosis in women with gynecologic malignancies after switching from raloxifene hydrochloride

Osaka University Graduate School of Medicine0 个研究点目标入组 50 人开始时间: 2014年5月10日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
Female

入选标准

  • 未提供

排除标准

  • Patients are excluded if being 1. with concomitant use of other agents for osteoporosis 2. with concomitant use of other agents, which potentially affect bone turnover 3. with esophageal stricture or achalasia 4. unable to remain upright for 30 min after dosing 5. with hypersensitivity to minodronate or other bisphosphonates 6. with hypocalcaemia 7. with aphagia, esophagitis, gastritis, duodenitis, or ulcers 8. with severe nephropathy 9. inappropriate to participate in the study

研究者

相似试验

Effect of monthly minodronate after switching from... | 临床试验